# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-25-002225
Filing Date
2025-11-28
Accepted
2025-11-26 20:35:55
Documents
87
Period of Report
2025-08-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | lxrp_10k.htm iXBRL | 10-K | 1399872
2 | ENGAGEMENT AGREEMENT | lxrp_ex1011.htm | EX-10.11 | 49519
3 | CONSENT | lxrp_ex231.htm | EX-23.1 | 1595
4 | CERTIFICATION | lxrp_ex311.htm | EX-31.1 | 9274
5 | CERTIFICATION | lxrp_ex312.htm | EX-31.2 | 9496
6 | CERTIFICATION | lxrp_ex321.htm | EX-32.1 | 4910
7 | CERTIFICATION | lxrp_ex322.htm | EX-32.2 | 5113
13 |  | lxrp_ex1011img1.jpg | GRAPHIC | 8936
| Complete submission text file | 0001640334-25-002225.txt |  | 6424431

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | lxrp-20250831.xsd | EX-101.SCH | 65407
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lxrp-20250831_lab.xml | EX-101.LAB | 359576
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | lxrp-20250831_cal.xml | EX-101.CAL | 51979
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lxrp-20250831_pre.xml | EX-101.PRE | 300780
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | lxrp-20250831_def.xml | EX-101.DEF | 151950
90 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrp_10k_htm.xml | XML | 973853

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 001-39874 | Film No.: 251532071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)